As per MRFR analysis, the biliary stent market size was estimated at 2.28 (USD Billion) in 2022. The biliary stent market industry is expected to grow from 2.43 (USD Billion) in 2023 to 4.2 (USD Billion) by 2032. The biliary stent market CAGR (growth rate) is expected to be around 6.29% during the forecast period (2024-2032).
Key market drivers include the rising prevalence of biliary diseases, such as primary sclerosing cholangitis (PSC) and cholangiocarcinoma, along with the increasing adoption of minimally invasive procedures. Additionally, technological advancements in stent design, such as the development of biodegradable and self-expanding stents, are fueling market growth. Emerging markets present significant opportunities for expansion, driven by growing healthcare infrastructure and increasing awareness about biliary diseases.
Recent trends in the biliary stent market include the shift towards patient-centric care, with a focus on improving patient outcomes and reducing procedural risks. This has led to the development of smaller, more flexible stents that can be placed with greater precision. Additionally, the emergence of artificial intelligence (AI) and machine learning (ML) technologies is expected to enhance diagnostic capabilities and optimize treatment strategies, further driving market growth in the coming years.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
A significant factor that drives the biliary stent market is the increasing prevalence of biliary diseases, including cholangiocarcinoma, gallstones, and pancreatitis. These conditions cause blockage of the bile ducts, a build-up of bile, and develop inflammation and pain along with a range of other complications, and biliary stents are considered as an optimal solution. Overall, because the number of people who are suffering from biliary diseases is steadily growing, the biliary stent market should develop in the next few years.
Continuous technological advancement of different devices has been the accelerator of Biliary Stent Market. There was the arrival of new materials into industrial use such as biocompatible polymers and the application of self-expanding stents making their application safer and more effective.
Some of the devices are modified to release antiproliferative or anti-inflammatory drugs to reduce the rate of blocking of the stent. With the advancement of such technology, the durability of these biliary stents is enhanced.
The increasing inclination towards minimally invasive procedures for treating biliary diseases is driving the need for biliary stents. Endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangiography are the reduced invasion techniques that facilitate the installation of biliary stents without open surgery.
These are associated with minimum risks, less-time of recovery and improved patient outcomes. With a rise in the minimally invasive procedures, the demand for biliary stent is anticipated to increase in the Biliary Stent Market.
The biliary stent market is segmented based on materials into plastic, metal, and biodegradable. Plastic stents are commonly used type of biliary stent, accounting for over 60% of the market revenue in 2023.
Plastic stents are made of polyethylene or polyurethane and are relatively inexpensive and easy to insert. However, they are also more likely to migrate or become clogged than metal stents. Metal stents are made of stainless steel or nitinol and are more durable and less likely to migrate or become clogged than plastic stents.
However, they are also more expensive and more difficult to insert. Metal stents are often used in patients who require long-term stenting or who have difficult anatomy. Biodegradable stents are made of materials that are gradually broken down by the body over time.
Biodegradable stents are less likely to cause long-term complications, such as stent migration or clogging. However, they are also more expensive than plastic or metal stents. The market for biodegradable stents is expected to grow rapidly in the coming years, as more and more surgeons become aware of their benefits.
The market for plastic stents is expected to remain the largest segment of the biliary stent market, but its share is expected to decline slightly over the next few years. Growth in the market is being driven by the increasing incidence of biliary diseases, such as cholangiocarcinoma and gallstones, and the growing adoption of minimally invasive surgical procedures.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The biliary stent market segmentation by design into single stent, double stent, and triple stent is a vital indicator of the market dynamics. In 2023, the single stent segment was dominant, and it is expected to account for around 55% of the market revenue. The rapid growth of this subsegment is fueled by the increasing use of stents for all types of clinical applications, which include the management of benign and malignant biliary obstructions.
The double stent segment will grow rapidly over the projected period as it imparts patency and does not allow the migration of the stent. Although niche, the triple stent segment would also witness significant growth due to the critical need in the management of complex biliary strictures and anastomosis. Overall, the biliary stent market segmentation by design is a complete representation of the market, which would allow the stakeholders to make informed decisions.
The biliary stent market is segmented by diameter into 7 Fr, 7 - 10 Fr, and > 10 Fr. In 2023, the 7 - 10 Fr segment held the largest market share, accounting for over 50% of the market revenue. The 7 Fr segment is expected to grow at the fastest CAGR during the forecast period, owing to the increasing adoption of minimally invasive procedures and the growing prevalence of biliary diseases.
The > 10 Fr segment is expected to witness steady growth, driven by the rising demand for larger-diameter stents for complex biliary strictures. Overall, the biliary stent market is expected to grow at a CAGR of 6.29% during the forecast period, reaching a market valuation of USD 4.2 billion by 2032.
The length of the biliary stent is a crucial factor in determining its applicability for specific clinical scenarios. The biliary stent market segmentation by length primarily comprises three categories: 10 cm, 10-20 cm, and > 20 cm.
Stents measuring 10 cm are often utilized for short-term biliary drainage, typically in cases of acute cholangitis or post-operative complications. These stents are designed to provide immediate relief of biliary obstruction while minimizing tissue trauma. Stents in the 10-20 cm range are commonly employed for intermediate-term biliary drainage, such as in patients with benign biliary strictures or following endoscopic sphincterotomy.
They offer a balance between efficacy and duration of patency, making them suitable for various clinical applications. Stents exceeding '20 cm' in length are primarily indicated for complex biliary interventions, including drainage of long-segment strictures or inoperable hilar cholangiocarcinomas. These stents provide extended reach and support, enabling effective drainage in challenging anatomical scenarios.
The biliary stent market revenue is expected to grow significantly in the coming years, driven by the increasing prevalence of biliary diseases and technological advancements in stent design. Strategic partnerships and mergers and acquisitions among market players are also shaping the industry landscape.
The biliary stent market is segmented based on application into benign biliary strictures, malignant biliary strictures, and choledocholithiasis. Among these, the malignant biliary strictures segment held the largest market share in 2023 and is projected to maintain its dominance throughout the forecast period.
The high prevalence of cholangiocarcinoma, the most common type of malignant biliary stricture, is a major factor driving the growth of this segment. Furthermore, the rising incidence of pancreatic cancer, which often causes malignant biliary obstruction, is also contributing to the market growth.
The benign biliary strictures segment is expected to witness significant growth over the forecast period due to the increasing prevalence of benign conditions such as choledocholithiasis and primary sclerosing cholangitis. The choledocholithiasis segment is also projected to grow steadily during the forecast period.
The biliary stent market is segmented into North America, Europe, APAC, South America, and MEA. North America accounted for the largest share of the market in 2023, owing to the high prevalence of chronic diseases such as cholangiocarcinoma and pancreatitis, as well as the increasing adoption of minimally invasive surgical procedures.
Europe is expected to witness significant growth over the forecast period due to the rising incidence of biliary tract diseases and the growing awareness about the benefits of biliary stents. APAC is projected to be the fastest-growing regional market, driven by the increasing healthcare expenditure, the rising geriatric population, and the growing prevalence of liver diseases. South America and MEA are expected to contribute a smaller share to the market but are expected to experience steady growth over the forecast period.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Leading players in the biliary stent market are increasingly focused on developing new products and expanding their range to cater for the growing demand for biliary stents. Partnership and collaboration in the manufacturing and distribution of biliary stents are an emerging trend in the sector as companies seek to leverage their combined experience and resources to deliver an enhanced product.
Another trend in the biliary stent market is the conscious investment by market participants in research and development to produce innovative technologies and seize growth opportunities in the industry. The leading players are a combination of the incumbents in the industry.
Boston Scientific Corporation is a US-based leading player in the development of the biliary stent market. The company boasts a robust portfolio of biliary stents reputed for their advanced design and clinical efficacy. Boston Scientific Corporation also benefits from its strong presence, its expansive distribution network, and expert team of professionals in the healthcare sector.
Boston Scientific Corporation has also demonstrated thought leadership in the industry, with the company being a trailblazer in innovative and patient-centered solutions in the treatment of biliary diseases. BSC is at the fore of research and development in the industry and regularly improves and expands its product range to meet the clinical needs in the market.
Another important player is Stryker Corporation. The company leverages its skills in the provision of medical technology to develop a range of biliary stents designed to address the clinical and anatomical needs of the patient. The company also invests in innovation, and stents by this company have been found to be superior in terms of biocompatibility, adequate drainage of blocked biliary stents, and are also associated with a lower incidence of complications.
Stryker Corporation also benefits from its reach and strong alliances with healthcare providers, which also enable the company to distribute the product all over the world and to provide comprehensive support to its customers.
The biliary stent market is anticipated to grow significantly over the forecast period, driven by factors such as the increasing prevalence of biliary diseases, the rising demand for minimally invasive procedures, and the technological advancements in stent design. The market is expected to witness a steady growth rate during the forecast period, reaching a market value of around USD 2.43 billion by 2023. Key players in the market include Boston Scientific, Cook Medical, and Olympus Corporation, among others.
Recent news developments in the market include the launch of new products, such as the fully covered, self-expanding biliary stent by Boston Scientific, and the acquisition of ELLA-CS by Medtronic, which is expected to strengthen Medtronic's position in the biliary stent market.
| Report Attribute/Metric | Details |
| Market Size 2022 | 2.28 (USD Billion) |
| Market Size 2023 | 2.43 (USD Billion) |
| Market Size 2032 | 4.2 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 6.29% (2024-2032) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2019-2023 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Smith & Nephew plc, Argon Medical Devices, Inc., Boston Scientific Corporation, Becton, Dickinson and Company, Alphatec Spine, Inc., DJO Surgical, Inc., ConMed Corporation, Olympus Corporation, Teleflex Incorporated, Stryker Corporation, Merit Medical Systems, Inc., Bard Peripheral Vascular, Inc., Cook Medical, Medtronic plc, NuVasive, Inc. |
| Segments Covered | Material, Design, Diameter, Length, Application, Region |
| Key Market Opportunities | Increasing Demand for Minimally Invasive Procedures Growing Prevalence of Biliary Tract Diseases Technological Advancements in Stent Design Expansion into Emerging Markets Rising Awareness about Biliary Stent Treatments |
| Key Market Dynamics | Increasing Prevalence of Biliary Diseases Technological Advancements Rising Demand for Minimally Invasive Procedures Growing Geriatric Population Expanding Healthcare Infrastructure |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The biliary stent market is projected to reach an overall valuation of 2.43 billion USD in 2023.
The biliary stent market is anticipated to grow at a CAGR of 6.29% from 2023 to 2032.
North America is expected to dominate the biliary stent market in 2023.
Biliary stents are primarily used to alleviate biliary obstruction caused by conditions such as tumors or gallstones.
Major competitors in the biliary stent market include Boston Scientific, Cook Medical, and Becton Dickinson.
The biliary stent market is projected to reach an overall valuation of 4.2 billion USD by 2032.
Factors driving the growth of the biliary stent market include the rising prevalence of biliary diseases and technological advancements in stent design.
Challenges faced by the biliary stent market include the availability of alternative treatment options and the risk of complications associated with stent placement.
Opportunities for growth in the biliary stent market include the development of novel stent materials and the expansion into emerging markets.
Key trends in the biliary stent market include the adoption of self-expandable stents and the increasing use of biodegradable stents.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
